CDC to Buy $2.3 Million of OraSure's HIV Antibody Tests
THE Philadelphia Inquirer
BY Porus P. Cooper
DECEMBER 23, 2004
Bethlehem, Pa.-based OraSure Technologies Inc. has announced that CDC will buy $2.3 million of its OraQuick Advance Rapid HIV-1/2 Antibody Test, which can detect antibodies to both HIV-1 and HIV-2. CDC bought $4 million of OraSure's OraQuick Rapid HIV-1 test last year. CDC distributes the tests to state health departments and public clinics.